atovaquone has been researched along with Histomoniasis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Birkenheuer, AJ; Cohn, LA; Levy, MG; Marr, HS; Schreeg, ME; Tarigo, J | 1 |
Anwar-Bruni, DM; Bryan, RT; Hogan, SE; Lennox, JL; Schwartz, DA; Wilcox, CM | 1 |
Baggish, AL; Hill, DR | 1 |
1 review(s) available for atovaquone and Histomoniasis
Article | Year |
---|---|
Antiparasitic agent atovaquone.
Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Babesia; Humans; Naphthoquinones; Plasmodium; Pneumocystis; Pneumonia, Pneumocystis; Protozoan Infections; Randomized Controlled Trials as Topic; Toxoplasma | 2002 |
2 other study(ies) available for atovaquone and Histomoniasis
Article | Year |
---|---|
Pharmacogenomics of Cytauxzoon felis cytochrome b: implications for atovaquone and azithromycin therapy in domestic cats with cytauxzoonosis.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Cat Diseases; Cats; Cytochromes b; Pharmacogenetics; Piroplasmida; Protozoan Infections | 2013 |
Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Atovaquone; Cohort Studies; HIV-1; Humans; Intestines; Male; Microsporida; Naphthoquinones; Protozoan Infections; Retrospective Studies | 1996 |